Visual improvement in central retinal vein occlusion (CRVO) following intravitreal injections of bevacizumab (Avastin®)

Autor: Johann Gudmundsson, Gunvor von Wendt, Peep V. Algvere, Anders Kvanta, Stefan Seregard
Rok vydání: 2010
Předmět:
Zdroj: Acta Ophthalmologica. 88:836-841
ISSN: 1755-375X
DOI: 10.1111/j.1755-3768.2009.01758.x
Popis: Acta Ophthalmol. 2010: 88: 836–841 Abstract. Purpose: To perform a prospective study on central retinal vein occlusion (CRVO) to evaluate whether visual acuity can be improved and macular oedema reduced in response to intravitreal injections of bevacizumab. Methods: The case material comprised 13 patients (aged 34–79 years), duration of CRVO was 2 weeks to 6 months, baseline ETDRS visual acuity 0.06–0.4 (mean Snellen 0.13, derived from logMAR value) and intraocular pressure (IOP) 12–20 (mean 15.2) mmHg. Clinical examination, including optical coherence tomography (OCT), was carried out at baseline and every 6 weeks, digital fluorescein angiography at baseline, at 3 months and 6 months. Intravitreal injections of bevacizumab (1.25 mg) were given under microscopic control at baseline and every 6 weeks during the 6-month follow-up. Results: Following one intravitreal injection of bevacizumab, average visual acuity improved by 13 ETDRS letters at 1 month (p
Databáze: OpenAIRE